Search

Author/Creator Buck, M

2. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy. (18th December 2017)

Authors:
Friedlander, M; Rau, J; Lee, C K; Meier, W; Lesoin, A; Kim, J -W; Poveda, A; Buck, M; Scambia, G; Shimada, M; Hilpert, F; King, M T; Debruyne, P; Bologna, A; Malander, S; Monk, B J; Petru, E; Calvert, P; Herzog, T J; Barrett, C
Journal:
Annals of oncology
Issue:
Volume 29:Number 3(2018)
Page Start:
737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T cells partly via transforming growth factor-β1. (2nd November 2016)

Authors:
Anderson, A E; Swan, D J; Wong, O Y; Buck, M; Eltherington, O; Harry, R A; Patterson, A M; Pratt, A G; Reynolds, G; Doran, J-P; Kirby, J A; Isaacs, J D; Hilkens, C M U
Journal:
Clinical and experimental immunology
Issue:
Volume 187:Number 1(2017:Jan.)
Page Start:
113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗